BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Science in Vancouver - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://scienceinvancouver.com
X-WR-CALDESC:Events for Science in Vancouver
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Vancouver
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20200308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20201101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20210314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20211107T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20220313T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20221106T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20211130T090000
DTEND;TZID=America/Vancouver:20211130T103000
DTSTAMP:20260405T050707
CREATED:20211021T182014Z
LAST-MODIFIED:20211021T182039Z
UID:18905-1638262800-1638268200@scienceinvancouver.com
SUMMARY:Townhall on the Future of Genomics in Canada
DESCRIPTION:Join us for a virtual townhall on the future of genomics in Canada (Nov. 30 at 9:00-10:30 AM PST) with Dr. Rob Annan\, President and CEO\, Genome Canada\, and Dr. Catalina Lopez-Correa\, Chief Scientific Officer\, Genome Canada.
URL:https://scienceinvancouver.com/event/townhall-on-the-future-of-genomics-in-canada/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20211130T090000
DTEND;TZID=America/Vancouver:20211130T103000
DTSTAMP:20260405T050707
CREATED:20211021T182014Z
LAST-MODIFIED:20211021T182014Z
UID:26452-1638262800-1638268200@scienceinvancouver.com
SUMMARY:Townhall on the Future of Genomics in Canada
DESCRIPTION:Join us for a virtual townhall on the future of genomics in Canada (Nov. 30 at 9:00-10:30 AM PST) with Dr. Rob Annan\, President and CEO\, Genome Canada\, and Dr. Catalina Lopez-Correa\, Chief Scientific Officer\, Genome Canada.
URL:https://scienceinvancouver.com/event/townhall-on-the-future-of-genomics-in-canada-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20211130T090000
DTEND;TZID=America/Vancouver:20211130T103000
DTSTAMP:20260405T050707
CREATED:20211021T182014Z
LAST-MODIFIED:20211021T182014Z
UID:28067-1638262800-1638268200@scienceinvancouver.com
SUMMARY:Townhall on the Future of Genomics in Canada
DESCRIPTION:Join us for a virtual townhall on the future of genomics in Canada (Nov. 30 at 9:00-10:30 AM PST) with Dr. Rob Annan\, President and CEO\, Genome Canada\, and Dr. Catalina Lopez-Correa\, Chief Scientific Officer\, Genome Canada.
URL:https://scienceinvancouver.com/event/townhall-on-the-future-of-genomics-in-canada-3/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20211130T090000
DTEND;TZID=America/Vancouver:20211130T103000
DTSTAMP:20260405T050707
CREATED:20211021T182014Z
LAST-MODIFIED:20211021T182014Z
UID:31150-1638262800-1638268200@scienceinvancouver.com
SUMMARY:Townhall on the Future of Genomics in Canada
DESCRIPTION:Join us for a virtual townhall on the future of genomics in Canada (Nov. 30 at 9:00-10:30 AM PST) with Dr. Rob Annan\, President and CEO\, Genome Canada\, and Dr. Catalina Lopez-Correa\, Chief Scientific Officer\, Genome Canada.
URL:https://scienceinvancouver.com/event/townhall-on-the-future-of-genomics-in-canada-4/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20211130T090000
DTEND;TZID=America/Vancouver:20211130T103000
DTSTAMP:20260405T050707
CREATED:20211021T182014Z
LAST-MODIFIED:20211021T182014Z
UID:32610-1638262800-1638268200@scienceinvancouver.com
SUMMARY:Townhall on the Future of Genomics in Canada
DESCRIPTION:Join us for a virtual townhall on the future of genomics in Canada (Nov. 30 at 9:00-10:30 AM PST) with Dr. Rob Annan\, President and CEO\, Genome Canada\, and Dr. Catalina Lopez-Correa\, Chief Scientific Officer\, Genome Canada.
URL:https://scienceinvancouver.com/event/townhall-on-the-future-of-genomics-in-canada-5/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20211130T100000
DTEND;TZID=America/Vancouver:20211130T123000
DTSTAMP:20260405T050707
CREATED:20211021T181012Z
LAST-MODIFIED:20211129T192044Z
UID:18897-1638266400-1638275400@scienceinvancouver.com
SUMMARY:COVID-19 Global Health Equity Symposium
DESCRIPTION:On behalf of the Neglected Global Diseases Initiative (NGDI) at the University of British Columbia and the organizing committee\, we would like to invite you to attend the COVID-19 Global Health Equity Symposium. There will be a number of local and international speakers that will share their field and research experiences with regards to the COVID-19 pandemic response and vaccination rollout in their healthcare settings. \nThe event is scheduled for November 30th\, 2021 and will be hybrid (hosted both on Zoom and at UBC\, Vancouver). \nTime: November 30\, 2021 from 10:00 AM to 12:30 PM PST. \nLocation: Life Sciences Center Room 1002\, UBC\, Vancouver. \n*Zoom ID and password will be shared closer to the symposium date.*
URL:https://scienceinvancouver.com/event/covid-19-global-health-equity-symposium/
LOCATION:Life Sciences Institute & Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20211130T100000
DTEND;TZID=America/Vancouver:20211130T123000
DTSTAMP:20260405T050707
CREATED:20211021T181012Z
LAST-MODIFIED:20211021T181012Z
UID:26450-1638266400-1638275400@scienceinvancouver.com
SUMMARY:COVID-19 Global Health Equity Symposium
DESCRIPTION:On behalf of the Neglected Global Diseases Initiative (NGDI) at the University of British Columbia and the organizing committee\, we would like to invite you to attend the COVID-19 Global Health Equity Symposium. There will be a number of local and international speakers that will share their field and research experiences with regards to the COVID-19 pandemic response and vaccination rollout in their healthcare settings. \nThe event is scheduled for November 30th\, 2021 and will be hybrid (hosted both on Zoom and at UBC\, Vancouver). \nTime: November 30\, 2021 from 10:00 AM to 12:30 PM PST. \nLocation: Life Sciences Center Room 1002\, UBC\, Vancouver. \n*Zoom ID and password will be shared closer to the symposium date.*
URL:https://scienceinvancouver.com/event/covid-19-global-health-equity-symposium-2/
LOCATION:Life Sciences Institute & Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20211130T100000
DTEND;TZID=America/Vancouver:20211130T123000
DTSTAMP:20260405T050707
CREATED:20211021T181012Z
LAST-MODIFIED:20211021T181012Z
UID:28065-1638266400-1638275400@scienceinvancouver.com
SUMMARY:COVID-19 Global Health Equity Symposium
DESCRIPTION:On behalf of the Neglected Global Diseases Initiative (NGDI) at the University of British Columbia and the organizing committee\, we would like to invite you to attend the COVID-19 Global Health Equity Symposium. There will be a number of local and international speakers that will share their field and research experiences with regards to the COVID-19 pandemic response and vaccination rollout in their healthcare settings. \nThe event is scheduled for November 30th\, 2021 and will be hybrid (hosted both on Zoom and at UBC\, Vancouver). \nTime: November 30\, 2021 from 10:00 AM to 12:30 PM PST. \nLocation: Life Sciences Center Room 1002\, UBC\, Vancouver. \n*Zoom ID and password will be shared closer to the symposium date.*
URL:https://scienceinvancouver.com/event/covid-19-global-health-equity-symposium-3/
LOCATION:Life Sciences Institute & Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20211130T100000
DTEND;TZID=America/Vancouver:20211130T123000
DTSTAMP:20260405T050707
CREATED:20211021T181012Z
LAST-MODIFIED:20211021T181012Z
UID:31148-1638266400-1638275400@scienceinvancouver.com
SUMMARY:COVID-19 Global Health Equity Symposium
DESCRIPTION:On behalf of the Neglected Global Diseases Initiative (NGDI) at the University of British Columbia and the organizing committee\, we would like to invite you to attend the COVID-19 Global Health Equity Symposium. There will be a number of local and international speakers that will share their field and research experiences with regards to the COVID-19 pandemic response and vaccination rollout in their healthcare settings. \nThe event is scheduled for November 30th\, 2021 and will be hybrid (hosted both on Zoom and at UBC\, Vancouver). \nTime: November 30\, 2021 from 10:00 AM to 12:30 PM PST. \nLocation: Life Sciences Center Room 1002\, UBC\, Vancouver. \n*Zoom ID and password will be shared closer to the symposium date.*
URL:https://scienceinvancouver.com/event/covid-19-global-health-equity-symposium-4/
LOCATION:Life Sciences Institute & Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20211130T100000
DTEND;TZID=America/Vancouver:20211130T123000
DTSTAMP:20260405T050707
CREATED:20211021T181012Z
LAST-MODIFIED:20211021T181012Z
UID:32608-1638266400-1638275400@scienceinvancouver.com
SUMMARY:COVID-19 Global Health Equity Symposium
DESCRIPTION:On behalf of the Neglected Global Diseases Initiative (NGDI) at the University of British Columbia and the organizing committee\, we would like to invite you to attend the COVID-19 Global Health Equity Symposium. There will be a number of local and international speakers that will share their field and research experiences with regards to the COVID-19 pandemic response and vaccination rollout in their healthcare settings. \nThe event is scheduled for November 30th\, 2021 and will be hybrid (hosted both on Zoom and at UBC\, Vancouver). \nTime: November 30\, 2021 from 10:00 AM to 12:30 PM PST. \nLocation: Life Sciences Center Room 1002\, UBC\, Vancouver. \n*Zoom ID and password will be shared closer to the symposium date.*
URL:https://scienceinvancouver.com/event/covid-19-global-health-equity-symposium-5/
LOCATION:Life Sciences Institute & Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20211130T120000
DTEND;TZID=America/Vancouver:20211130T133000
DTSTAMP:20260405T050707
CREATED:20211110T191331Z
LAST-MODIFIED:20211110T191331Z
UID:19301-1638273600-1638279000@scienceinvancouver.com
SUMMARY:Technology Meets Biology: Changing How We Fight Disease
DESCRIPTION:Immerse yourself into the future of medicine – where virtual reality headsets help doctors diagnose neurodegenerative diseases before symptoms appear\, where engineered stem cells regenerate the body to treat disease and wearable motion sensors capture injuries as they occur in real life. This is biomedical engineering. \nBiomedical engineering combines engineering and design principles with biology and medicine. Collaboration among diverse minds at the UBC School of Biomedical Engineering has the potential to yield massive leaps forward in how we prevent\, manage and treat disease. \nHear from UBC experts Dr. Calvin Kuo\, Dr. Manu Madhav and Dr. Nika Shakiba about how the School of Biomedical Engineering is building a bold and boundless community of collaboration\, research and clinical expertise fueled by patient experience to bring interdisciplinary\, tailor-made medical solutions to patients faster and make them available to everyone. Dr. Peter Zandstra\, Director of the School of Biomedical Engineering\, will introduce the webinar topic.
URL:https://scienceinvancouver.com/event/technology-meets-biology-changing-how-we-fight-disease/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20211130T120000
DTEND;TZID=America/Vancouver:20211130T133000
DTSTAMP:20260405T050707
CREATED:20211110T191331Z
LAST-MODIFIED:20211110T191331Z
UID:26464-1638273600-1638279000@scienceinvancouver.com
SUMMARY:Technology Meets Biology: Changing How We Fight Disease
DESCRIPTION:Immerse yourself into the future of medicine – where virtual reality headsets help doctors diagnose neurodegenerative diseases before symptoms appear\, where engineered stem cells regenerate the body to treat disease and wearable motion sensors capture injuries as they occur in real life. This is biomedical engineering. \nBiomedical engineering combines engineering and design principles with biology and medicine. Collaboration among diverse minds at the UBC School of Biomedical Engineering has the potential to yield massive leaps forward in how we prevent\, manage and treat disease. \nHear from UBC experts Dr. Calvin Kuo\, Dr. Manu Madhav and Dr. Nika Shakiba about how the School of Biomedical Engineering is building a bold and boundless community of collaboration\, research and clinical expertise fueled by patient experience to bring interdisciplinary\, tailor-made medical solutions to patients faster and make them available to everyone. Dr. Peter Zandstra\, Director of the School of Biomedical Engineering\, will introduce the webinar topic.
URL:https://scienceinvancouver.com/event/technology-meets-biology-changing-how-we-fight-disease-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20211130T120000
DTEND;TZID=America/Vancouver:20211130T133000
DTSTAMP:20260405T050707
CREATED:20211110T191331Z
LAST-MODIFIED:20211110T191331Z
UID:28081-1638273600-1638279000@scienceinvancouver.com
SUMMARY:Technology Meets Biology: Changing How We Fight Disease
DESCRIPTION:Immerse yourself into the future of medicine – where virtual reality headsets help doctors diagnose neurodegenerative diseases before symptoms appear\, where engineered stem cells regenerate the body to treat disease and wearable motion sensors capture injuries as they occur in real life. This is biomedical engineering. \nBiomedical engineering combines engineering and design principles with biology and medicine. Collaboration among diverse minds at the UBC School of Biomedical Engineering has the potential to yield massive leaps forward in how we prevent\, manage and treat disease. \nHear from UBC experts Dr. Calvin Kuo\, Dr. Manu Madhav and Dr. Nika Shakiba about how the School of Biomedical Engineering is building a bold and boundless community of collaboration\, research and clinical expertise fueled by patient experience to bring interdisciplinary\, tailor-made medical solutions to patients faster and make them available to everyone. Dr. Peter Zandstra\, Director of the School of Biomedical Engineering\, will introduce the webinar topic.
URL:https://scienceinvancouver.com/event/technology-meets-biology-changing-how-we-fight-disease-3/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20211130T120000
DTEND;TZID=America/Vancouver:20211130T133000
DTSTAMP:20260405T050707
CREATED:20211110T191331Z
LAST-MODIFIED:20211110T191331Z
UID:31164-1638273600-1638279000@scienceinvancouver.com
SUMMARY:Technology Meets Biology: Changing How We Fight Disease
DESCRIPTION:Immerse yourself into the future of medicine – where virtual reality headsets help doctors diagnose neurodegenerative diseases before symptoms appear\, where engineered stem cells regenerate the body to treat disease and wearable motion sensors capture injuries as they occur in real life. This is biomedical engineering. \nBiomedical engineering combines engineering and design principles with biology and medicine. Collaboration among diverse minds at the UBC School of Biomedical Engineering has the potential to yield massive leaps forward in how we prevent\, manage and treat disease. \nHear from UBC experts Dr. Calvin Kuo\, Dr. Manu Madhav and Dr. Nika Shakiba about how the School of Biomedical Engineering is building a bold and boundless community of collaboration\, research and clinical expertise fueled by patient experience to bring interdisciplinary\, tailor-made medical solutions to patients faster and make them available to everyone. Dr. Peter Zandstra\, Director of the School of Biomedical Engineering\, will introduce the webinar topic.
URL:https://scienceinvancouver.com/event/technology-meets-biology-changing-how-we-fight-disease-4/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20211130T120000
DTEND;TZID=America/Vancouver:20211130T133000
DTSTAMP:20260405T050707
CREATED:20211110T191331Z
LAST-MODIFIED:20211110T191331Z
UID:32624-1638273600-1638279000@scienceinvancouver.com
SUMMARY:Technology Meets Biology: Changing How We Fight Disease
DESCRIPTION:Immerse yourself into the future of medicine – where virtual reality headsets help doctors diagnose neurodegenerative diseases before symptoms appear\, where engineered stem cells regenerate the body to treat disease and wearable motion sensors capture injuries as they occur in real life. This is biomedical engineering. \nBiomedical engineering combines engineering and design principles with biology and medicine. Collaboration among diverse minds at the UBC School of Biomedical Engineering has the potential to yield massive leaps forward in how we prevent\, manage and treat disease. \nHear from UBC experts Dr. Calvin Kuo\, Dr. Manu Madhav and Dr. Nika Shakiba about how the School of Biomedical Engineering is building a bold and boundless community of collaboration\, research and clinical expertise fueled by patient experience to bring interdisciplinary\, tailor-made medical solutions to patients faster and make them available to everyone. Dr. Peter Zandstra\, Director of the School of Biomedical Engineering\, will introduce the webinar topic.
URL:https://scienceinvancouver.com/event/technology-meets-biology-changing-how-we-fight-disease-5/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20211130T153000
DTEND;TZID=America/Vancouver:20211130T170000
DTSTAMP:20260405T050707
CREATED:20211124T170803Z
LAST-MODIFIED:20211124T170803Z
UID:19527-1638286200-1638291600@scienceinvancouver.com
SUMMARY:BioTech Trends and Must Have Skills for Career Success
DESCRIPTION:Are you wondering if you have the essential skills in creating a successful career in the Canadian bio-economy? Get to know more!\n\n\n\n\n\nAbout this event\n\n\n‘Transferable job skills just meant communication skills.’ \n“Why would a hiring manager reject a science Ph.D. from a biotech job just because he lacks budgeting skills? I don’t get it.” \n“What skills stand out on Biotechnologist resumes?” \nAre we in the dilemma of figuring out what are the essential skills that we have to get a job in the biotech or pharma industry? \nThe Canadian biotechnology and life sciences sector is a significant contributor to Canada’s innovation economy\, and one of the country’s fastest-growing industries. Across Canada\, 33% of biotechnology and life sciences\, employers report skills shortages and 20% have job vacancies in their companies. (Source: Vancouver Public library). \nReady to take this challenge and have the thirst to learn more? \nJoin this event brought to you by the IWS Network in collaboration with adMare aiming to obtain a better understanding of the biotech trends and essential job skills needed to make your mark in the Biotech and Biopharma industry. During this hour\, you will learn in more detail about adMare and engage in dialogue with Dr. Edie Dullaghan\, who will share her experiences. \nAgenda: \n• Welcome Remarks – IWS Network \n• Introduction of AdMare \n• Speaker session \n• Virtual networking \n\n\nAbout the Speaker:\nDr. Edie Dullaghan\, Scientific Director\, adMare Academy\, adMare BioInnovations\, Vancouver\, BC\nAs the Scientific Director of the adMare Academy\, Dr. Edie Dullaghan plays a direct role in the development and advancement of scientific talent within the Canadian life sciences ecosystem. At adMare\, Dr. Dullaghan supports the Academy’s programs\, including The BioInnovation Scientist Program\, a one-of-a-kind program for early-career scientists looking to build a drug development and commercialization career in Canada’s life sciences industry. \nPreviously\, Dr. Dullaghan worked at CDRD – The Centre for Drug Research and Development as the Director of Target Validation\, where she spent over ten years advancing made-in-Canada innovations while also mentoring the next generation of drug developers. Prior to joining CDRD\, Dr. Dullaghan served as the Pathogenomics Project Leader for Inimex Pharmaceuticals Inc.\, developing robust animal models of human infections with a focus on host defence peptides and small molecules. Over the course of her career\, she has managed several large-scale R&D programs\, including leading a global collaboration with LifeArc and The Defence Science and Technology Laboratories (DSTL) in the United Kingdom using a novel approach in drug target discovery that capitalizes on areas of commonality across pathogens. \nDr. Dullaghan obtained her Ph.D. in the U.K. at the National Institute for Medical Research\, studying the molecular genetics of the SOS response in Mycobacterium tuberculosis\, the causative agent of TB.
URL:https://scienceinvancouver.com/event/biotech-trends-and-must-have-skills-for-career-success/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2021/11/BioTech-Trends-and-Must-have-Skills-for-Career-Success.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20211130T153000
DTEND;TZID=America/Vancouver:20211130T170000
DTSTAMP:20260405T050708
CREATED:20211124T170803Z
LAST-MODIFIED:20211124T170803Z
UID:26474-1638286200-1638291600@scienceinvancouver.com
SUMMARY:BioTech Trends and Must Have Skills for Career Success
DESCRIPTION:Are you wondering if you have the essential skills in creating a successful career in the Canadian bio-economy? Get to know more!\n\n\n\n\n\nAbout this event\n\n\n‘Transferable job skills just meant communication skills.’ \n“Why would a hiring manager reject a science Ph.D. from a biotech job just because he lacks budgeting skills? I don’t get it.” \n“What skills stand out on Biotechnologist resumes?” \nAre we in the dilemma of figuring out what are the essential skills that we have to get a job in the biotech or pharma industry? \nThe Canadian biotechnology and life sciences sector is a significant contributor to Canada’s innovation economy\, and one of the country’s fastest-growing industries. Across Canada\, 33% of biotechnology and life sciences\, employers report skills shortages and 20% have job vacancies in their companies. (Source: Vancouver Public library). \nReady to take this challenge and have the thirst to learn more? \nJoin this event brought to you by the IWS Network in collaboration with adMare aiming to obtain a better understanding of the biotech trends and essential job skills needed to make your mark in the Biotech and Biopharma industry. During this hour\, you will learn in more detail about adMare and engage in dialogue with Dr. Edie Dullaghan\, who will share her experiences. \nAgenda: \n• Welcome Remarks – IWS Network \n• Introduction of AdMare \n• Speaker session \n• Virtual networking \n\n\nAbout the Speaker:\nDr. Edie Dullaghan\, Scientific Director\, adMare Academy\, adMare BioInnovations\, Vancouver\, BC\nAs the Scientific Director of the adMare Academy\, Dr. Edie Dullaghan plays a direct role in the development and advancement of scientific talent within the Canadian life sciences ecosystem. At adMare\, Dr. Dullaghan supports the Academy’s programs\, including The BioInnovation Scientist Program\, a one-of-a-kind program for early-career scientists looking to build a drug development and commercialization career in Canada’s life sciences industry. \nPreviously\, Dr. Dullaghan worked at CDRD – The Centre for Drug Research and Development as the Director of Target Validation\, where she spent over ten years advancing made-in-Canada innovations while also mentoring the next generation of drug developers. Prior to joining CDRD\, Dr. Dullaghan served as the Pathogenomics Project Leader for Inimex Pharmaceuticals Inc.\, developing robust animal models of human infections with a focus on host defence peptides and small molecules. Over the course of her career\, she has managed several large-scale R&D programs\, including leading a global collaboration with LifeArc and The Defence Science and Technology Laboratories (DSTL) in the United Kingdom using a novel approach in drug target discovery that capitalizes on areas of commonality across pathogens. \nDr. Dullaghan obtained her Ph.D. in the U.K. at the National Institute for Medical Research\, studying the molecular genetics of the SOS response in Mycobacterium tuberculosis\, the causative agent of TB.
URL:https://scienceinvancouver.com/event/biotech-trends-and-must-have-skills-for-career-success-2/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2021/11/BioTech-Trends-and-Must-have-Skills-for-Career-Success.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20211130T153000
DTEND;TZID=America/Vancouver:20211130T170000
DTSTAMP:20260405T050708
CREATED:20211124T170803Z
LAST-MODIFIED:20211124T170803Z
UID:28089-1638286200-1638291600@scienceinvancouver.com
SUMMARY:BioTech Trends and Must Have Skills for Career Success
DESCRIPTION:Are you wondering if you have the essential skills in creating a successful career in the Canadian bio-economy? Get to know more!\n\n\n\n\n\nAbout this event\n\n\n‘Transferable job skills just meant communication skills.’ \n“Why would a hiring manager reject a science Ph.D. from a biotech job just because he lacks budgeting skills? I don’t get it.” \n“What skills stand out on Biotechnologist resumes?” \nAre we in the dilemma of figuring out what are the essential skills that we have to get a job in the biotech or pharma industry? \nThe Canadian biotechnology and life sciences sector is a significant contributor to Canada’s innovation economy\, and one of the country’s fastest-growing industries. Across Canada\, 33% of biotechnology and life sciences\, employers report skills shortages and 20% have job vacancies in their companies. (Source: Vancouver Public library). \nReady to take this challenge and have the thirst to learn more? \nJoin this event brought to you by the IWS Network in collaboration with adMare aiming to obtain a better understanding of the biotech trends and essential job skills needed to make your mark in the Biotech and Biopharma industry. During this hour\, you will learn in more detail about adMare and engage in dialogue with Dr. Edie Dullaghan\, who will share her experiences. \nAgenda: \n• Welcome Remarks – IWS Network \n• Introduction of AdMare \n• Speaker session \n• Virtual networking \n\n\nAbout the Speaker:\nDr. Edie Dullaghan\, Scientific Director\, adMare Academy\, adMare BioInnovations\, Vancouver\, BC\nAs the Scientific Director of the adMare Academy\, Dr. Edie Dullaghan plays a direct role in the development and advancement of scientific talent within the Canadian life sciences ecosystem. At adMare\, Dr. Dullaghan supports the Academy’s programs\, including The BioInnovation Scientist Program\, a one-of-a-kind program for early-career scientists looking to build a drug development and commercialization career in Canada’s life sciences industry. \nPreviously\, Dr. Dullaghan worked at CDRD – The Centre for Drug Research and Development as the Director of Target Validation\, where she spent over ten years advancing made-in-Canada innovations while also mentoring the next generation of drug developers. Prior to joining CDRD\, Dr. Dullaghan served as the Pathogenomics Project Leader for Inimex Pharmaceuticals Inc.\, developing robust animal models of human infections with a focus on host defence peptides and small molecules. Over the course of her career\, she has managed several large-scale R&D programs\, including leading a global collaboration with LifeArc and The Defence Science and Technology Laboratories (DSTL) in the United Kingdom using a novel approach in drug target discovery that capitalizes on areas of commonality across pathogens. \nDr. Dullaghan obtained her Ph.D. in the U.K. at the National Institute for Medical Research\, studying the molecular genetics of the SOS response in Mycobacterium tuberculosis\, the causative agent of TB.
URL:https://scienceinvancouver.com/event/biotech-trends-and-must-have-skills-for-career-success-3/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2021/11/BioTech-Trends-and-Must-have-Skills-for-Career-Success.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20211130T153000
DTEND;TZID=America/Vancouver:20211130T170000
DTSTAMP:20260405T050708
CREATED:20211124T170803Z
LAST-MODIFIED:20211124T170803Z
UID:31172-1638286200-1638291600@scienceinvancouver.com
SUMMARY:BioTech Trends and Must Have Skills for Career Success
DESCRIPTION:Are you wondering if you have the essential skills in creating a successful career in the Canadian bio-economy? Get to know more!\n\n\n\n\n\nAbout this event\n\n\n‘Transferable job skills just meant communication skills.’ \n“Why would a hiring manager reject a science Ph.D. from a biotech job just because he lacks budgeting skills? I don’t get it.” \n“What skills stand out on Biotechnologist resumes?” \nAre we in the dilemma of figuring out what are the essential skills that we have to get a job in the biotech or pharma industry? \nThe Canadian biotechnology and life sciences sector is a significant contributor to Canada’s innovation economy\, and one of the country’s fastest-growing industries. Across Canada\, 33% of biotechnology and life sciences\, employers report skills shortages and 20% have job vacancies in their companies. (Source: Vancouver Public library). \nReady to take this challenge and have the thirst to learn more? \nJoin this event brought to you by the IWS Network in collaboration with adMare aiming to obtain a better understanding of the biotech trends and essential job skills needed to make your mark in the Biotech and Biopharma industry. During this hour\, you will learn in more detail about adMare and engage in dialogue with Dr. Edie Dullaghan\, who will share her experiences. \nAgenda: \n• Welcome Remarks – IWS Network \n• Introduction of AdMare \n• Speaker session \n• Virtual networking \n\n\nAbout the Speaker:\nDr. Edie Dullaghan\, Scientific Director\, adMare Academy\, adMare BioInnovations\, Vancouver\, BC\nAs the Scientific Director of the adMare Academy\, Dr. Edie Dullaghan plays a direct role in the development and advancement of scientific talent within the Canadian life sciences ecosystem. At adMare\, Dr. Dullaghan supports the Academy’s programs\, including The BioInnovation Scientist Program\, a one-of-a-kind program for early-career scientists looking to build a drug development and commercialization career in Canada’s life sciences industry. \nPreviously\, Dr. Dullaghan worked at CDRD – The Centre for Drug Research and Development as the Director of Target Validation\, where she spent over ten years advancing made-in-Canada innovations while also mentoring the next generation of drug developers. Prior to joining CDRD\, Dr. Dullaghan served as the Pathogenomics Project Leader for Inimex Pharmaceuticals Inc.\, developing robust animal models of human infections with a focus on host defence peptides and small molecules. Over the course of her career\, she has managed several large-scale R&D programs\, including leading a global collaboration with LifeArc and The Defence Science and Technology Laboratories (DSTL) in the United Kingdom using a novel approach in drug target discovery that capitalizes on areas of commonality across pathogens. \nDr. Dullaghan obtained her Ph.D. in the U.K. at the National Institute for Medical Research\, studying the molecular genetics of the SOS response in Mycobacterium tuberculosis\, the causative agent of TB.
URL:https://scienceinvancouver.com/event/biotech-trends-and-must-have-skills-for-career-success-4/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2021/11/BioTech-Trends-and-Must-have-Skills-for-Career-Success.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20211130T153000
DTEND;TZID=America/Vancouver:20211130T170000
DTSTAMP:20260405T050708
CREATED:20211124T170803Z
LAST-MODIFIED:20211124T170803Z
UID:32632-1638286200-1638291600@scienceinvancouver.com
SUMMARY:BioTech Trends and Must Have Skills for Career Success
DESCRIPTION:Are you wondering if you have the essential skills in creating a successful career in the Canadian bio-economy? Get to know more!\n\n\n\n\n\nAbout this event\n\n\n‘Transferable job skills just meant communication skills.’ \n“Why would a hiring manager reject a science Ph.D. from a biotech job just because he lacks budgeting skills? I don’t get it.” \n“What skills stand out on Biotechnologist resumes?” \nAre we in the dilemma of figuring out what are the essential skills that we have to get a job in the biotech or pharma industry? \nThe Canadian biotechnology and life sciences sector is a significant contributor to Canada’s innovation economy\, and one of the country’s fastest-growing industries. Across Canada\, 33% of biotechnology and life sciences\, employers report skills shortages and 20% have job vacancies in their companies. (Source: Vancouver Public library). \nReady to take this challenge and have the thirst to learn more? \nJoin this event brought to you by the IWS Network in collaboration with adMare aiming to obtain a better understanding of the biotech trends and essential job skills needed to make your mark in the Biotech and Biopharma industry. During this hour\, you will learn in more detail about adMare and engage in dialogue with Dr. Edie Dullaghan\, who will share her experiences. \nAgenda: \n• Welcome Remarks – IWS Network \n• Introduction of AdMare \n• Speaker session \n• Virtual networking \n\n\nAbout the Speaker:\nDr. Edie Dullaghan\, Scientific Director\, adMare Academy\, adMare BioInnovations\, Vancouver\, BC\nAs the Scientific Director of the adMare Academy\, Dr. Edie Dullaghan plays a direct role in the development and advancement of scientific talent within the Canadian life sciences ecosystem. At adMare\, Dr. Dullaghan supports the Academy’s programs\, including The BioInnovation Scientist Program\, a one-of-a-kind program for early-career scientists looking to build a drug development and commercialization career in Canada’s life sciences industry. \nPreviously\, Dr. Dullaghan worked at CDRD – The Centre for Drug Research and Development as the Director of Target Validation\, where she spent over ten years advancing made-in-Canada innovations while also mentoring the next generation of drug developers. Prior to joining CDRD\, Dr. Dullaghan served as the Pathogenomics Project Leader for Inimex Pharmaceuticals Inc.\, developing robust animal models of human infections with a focus on host defence peptides and small molecules. Over the course of her career\, she has managed several large-scale R&D programs\, including leading a global collaboration with LifeArc and The Defence Science and Technology Laboratories (DSTL) in the United Kingdom using a novel approach in drug target discovery that capitalizes on areas of commonality across pathogens. \nDr. Dullaghan obtained her Ph.D. in the U.K. at the National Institute for Medical Research\, studying the molecular genetics of the SOS response in Mycobacterium tuberculosis\, the causative agent of TB.
URL:https://scienceinvancouver.com/event/biotech-trends-and-must-have-skills-for-career-success-5/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2021/11/BioTech-Trends-and-Must-have-Skills-for-Career-Success.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20211201T100000
DTEND;TZID=America/Vancouver:20211201T110000
DTSTAMP:20260405T050708
CREATED:20211117T004408Z
LAST-MODIFIED:20211127T002757Z
UID:19406-1638352800-1638356400@scienceinvancouver.com
SUMMARY:World AIDS Day: COVID\, Inequality & the Future of HIV
DESCRIPTION:This year marks forty years since the first case of AIDS was reported. While we have the tools and knowledge to address HIV and AIDS\, the world is failing to meet many of the targets set out by the international community as we enter the fifth decade of the pandemic. In Canada and around the world\, persistent and unaddressed social and structural inequalities continue to confound efforts to address the crisis. In the past two years\, we have also witnessed the impact of these inequalities as they have been further exposed\, and exploited\, by the COVID-19 pandemic. \nAligned with the UNAIDS theme of “End inequalities\, End AIDS\, End pandemics”\, the CTN is excited to offer a diverse set of speakers to discuss these important topics\, including recent advances in HIV vaccines\, what we have learned about COVID-19 in people living with HIV\, and the pervasive impact of social inequalities on our collective goals. \nDr. Rupert Kaul will discuss the latest developments in the pursuit of HIV vaccines\, as well as the possibility of a functional cure. \nDrs. Ann Burchell and Cecilia Costiniuk will describe the research being done to assess the effectiveness of the COVID-19 vaccine in people living with HIV. \nDr. Pascal Djiadeu will be discussing the intersection of COVID-19 and the HIV/AIDS pandemic through the lens of social determinants of health. \nWe have also recognized that people may be growing tired of traditional webinars and virtual talks\, so we have planned something more creative and engaging. The event this year will feature short\, image-focused presentations\, which will be followed by audience questions\, emceed by Shari Margolese\, the Community Co-Lead of the CTN’s Cross-Core Community Collaborative (C4) teams. \nEveryone is welcome (& it’s free)!
URL:https://scienceinvancouver.com/event/world-aids-day-covid-inequality-the-future-of-hiv/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2021/11/Zoom-banner_World-AIDS-Day_v1-980x306-1.png
ORGANIZER;CN="CIHR Canadian HIV Trials Network":MAILTO:ctninfo@hivnet.ubc.ca
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20211201T100000
DTEND;TZID=America/Vancouver:20211201T110000
DTSTAMP:20260405T050708
CREATED:20211117T004408Z
LAST-MODIFIED:20211117T004408Z
UID:26472-1638352800-1638356400@scienceinvancouver.com
SUMMARY:World AIDS Day: COVID\, Inequality & the Future of HIV
DESCRIPTION:This year marks forty years since the first case of AIDS was reported. While we have the tools and knowledge to address HIV and AIDS\, the world is failing to meet many of the targets set out by the international community as we enter the fifth decade of the pandemic. In Canada and around the world\, persistent and unaddressed social and structural inequalities continue to confound efforts to address the crisis. In the past two years\, we have also witnessed the impact of these inequalities as they have been further exposed\, and exploited\, by the COVID-19 pandemic. \nAligned with the UNAIDS theme of “End inequalities\, End AIDS\, End pandemics”\, the CTN is excited to offer a diverse set of speakers to discuss these important topics\, including recent advances in HIV vaccines\, what we have learned about COVID-19 in people living with HIV\, and the pervasive impact of social inequalities on our collective goals. \nDr. Rupert Kaul will discuss the latest developments in the pursuit of HIV vaccines\, as well as the possibility of a functional cure. \nDrs. Ann Burchell and Cecilia Costiniuk will describe the research being done to assess the effectiveness of the COVID-19 vaccine in people living with HIV. \nDr. Pascal Djiadeu will be discussing the intersection of COVID-19 and the HIV/AIDS pandemic through the lens of social determinants of health. \nWe have also recognized that people may be growing tired of traditional webinars and virtual talks\, so we have planned something more creative and engaging. The event this year will feature short\, image-focused presentations\, which will be followed by audience questions\, emceed by Shari Margolese\, the Community Co-Lead of the CTN’s Cross-Core Community Collaborative (C4) teams. \nEveryone is welcome (& it’s free)!
URL:https://scienceinvancouver.com/event/world-aids-day-covid-inequality-the-future-of-hiv-2/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2021/11/Zoom-banner_World-AIDS-Day_v1-980x306-1.png
ORGANIZER;CN="CIHR Canadian HIV Trials Network":MAILTO:ctninfo@hivnet.ubc.ca
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20211201T100000
DTEND;TZID=America/Vancouver:20211201T110000
DTSTAMP:20260405T050708
CREATED:20211117T004408Z
LAST-MODIFIED:20211117T004408Z
UID:28087-1638352800-1638356400@scienceinvancouver.com
SUMMARY:World AIDS Day: COVID\, Inequality & the Future of HIV
DESCRIPTION:This year marks forty years since the first case of AIDS was reported. While we have the tools and knowledge to address HIV and AIDS\, the world is failing to meet many of the targets set out by the international community as we enter the fifth decade of the pandemic. In Canada and around the world\, persistent and unaddressed social and structural inequalities continue to confound efforts to address the crisis. In the past two years\, we have also witnessed the impact of these inequalities as they have been further exposed\, and exploited\, by the COVID-19 pandemic. \nAligned with the UNAIDS theme of “End inequalities\, End AIDS\, End pandemics”\, the CTN is excited to offer a diverse set of speakers to discuss these important topics\, including recent advances in HIV vaccines\, what we have learned about COVID-19 in people living with HIV\, and the pervasive impact of social inequalities on our collective goals. \nDr. Rupert Kaul will discuss the latest developments in the pursuit of HIV vaccines\, as well as the possibility of a functional cure. \nDrs. Ann Burchell and Cecilia Costiniuk will describe the research being done to assess the effectiveness of the COVID-19 vaccine in people living with HIV. \nDr. Pascal Djiadeu will be discussing the intersection of COVID-19 and the HIV/AIDS pandemic through the lens of social determinants of health. \nWe have also recognized that people may be growing tired of traditional webinars and virtual talks\, so we have planned something more creative and engaging. The event this year will feature short\, image-focused presentations\, which will be followed by audience questions\, emceed by Shari Margolese\, the Community Co-Lead of the CTN’s Cross-Core Community Collaborative (C4) teams. \nEveryone is welcome (& it’s free)!
URL:https://scienceinvancouver.com/event/world-aids-day-covid-inequality-the-future-of-hiv-3/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2021/11/Zoom-banner_World-AIDS-Day_v1-980x306-1.png
ORGANIZER;CN="CIHR Canadian HIV Trials Network":MAILTO:ctninfo@hivnet.ubc.ca
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20211201T100000
DTEND;TZID=America/Vancouver:20211201T110000
DTSTAMP:20260405T050708
CREATED:20211117T004408Z
LAST-MODIFIED:20211117T004408Z
UID:31170-1638352800-1638356400@scienceinvancouver.com
SUMMARY:World AIDS Day: COVID\, Inequality & the Future of HIV
DESCRIPTION:This year marks forty years since the first case of AIDS was reported. While we have the tools and knowledge to address HIV and AIDS\, the world is failing to meet many of the targets set out by the international community as we enter the fifth decade of the pandemic. In Canada and around the world\, persistent and unaddressed social and structural inequalities continue to confound efforts to address the crisis. In the past two years\, we have also witnessed the impact of these inequalities as they have been further exposed\, and exploited\, by the COVID-19 pandemic. \nAligned with the UNAIDS theme of “End inequalities\, End AIDS\, End pandemics”\, the CTN is excited to offer a diverse set of speakers to discuss these important topics\, including recent advances in HIV vaccines\, what we have learned about COVID-19 in people living with HIV\, and the pervasive impact of social inequalities on our collective goals. \nDr. Rupert Kaul will discuss the latest developments in the pursuit of HIV vaccines\, as well as the possibility of a functional cure. \nDrs. Ann Burchell and Cecilia Costiniuk will describe the research being done to assess the effectiveness of the COVID-19 vaccine in people living with HIV. \nDr. Pascal Djiadeu will be discussing the intersection of COVID-19 and the HIV/AIDS pandemic through the lens of social determinants of health. \nWe have also recognized that people may be growing tired of traditional webinars and virtual talks\, so we have planned something more creative and engaging. The event this year will feature short\, image-focused presentations\, which will be followed by audience questions\, emceed by Shari Margolese\, the Community Co-Lead of the CTN’s Cross-Core Community Collaborative (C4) teams. \nEveryone is welcome (& it’s free)!
URL:https://scienceinvancouver.com/event/world-aids-day-covid-inequality-the-future-of-hiv-4/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2021/11/Zoom-banner_World-AIDS-Day_v1-980x306-1.png
ORGANIZER;CN="CIHR Canadian HIV Trials Network":MAILTO:ctninfo@hivnet.ubc.ca
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20211201T100000
DTEND;TZID=America/Vancouver:20211201T110000
DTSTAMP:20260405T050708
CREATED:20211117T004408Z
LAST-MODIFIED:20211117T004408Z
UID:32630-1638352800-1638356400@scienceinvancouver.com
SUMMARY:World AIDS Day: COVID\, Inequality & the Future of HIV
DESCRIPTION:This year marks forty years since the first case of AIDS was reported. While we have the tools and knowledge to address HIV and AIDS\, the world is failing to meet many of the targets set out by the international community as we enter the fifth decade of the pandemic. In Canada and around the world\, persistent and unaddressed social and structural inequalities continue to confound efforts to address the crisis. In the past two years\, we have also witnessed the impact of these inequalities as they have been further exposed\, and exploited\, by the COVID-19 pandemic. \nAligned with the UNAIDS theme of “End inequalities\, End AIDS\, End pandemics”\, the CTN is excited to offer a diverse set of speakers to discuss these important topics\, including recent advances in HIV vaccines\, what we have learned about COVID-19 in people living with HIV\, and the pervasive impact of social inequalities on our collective goals. \nDr. Rupert Kaul will discuss the latest developments in the pursuit of HIV vaccines\, as well as the possibility of a functional cure. \nDrs. Ann Burchell and Cecilia Costiniuk will describe the research being done to assess the effectiveness of the COVID-19 vaccine in people living with HIV. \nDr. Pascal Djiadeu will be discussing the intersection of COVID-19 and the HIV/AIDS pandemic through the lens of social determinants of health. \nWe have also recognized that people may be growing tired of traditional webinars and virtual talks\, so we have planned something more creative and engaging. The event this year will feature short\, image-focused presentations\, which will be followed by audience questions\, emceed by Shari Margolese\, the Community Co-Lead of the CTN’s Cross-Core Community Collaborative (C4) teams. \nEveryone is welcome (& it’s free)!
URL:https://scienceinvancouver.com/event/world-aids-day-covid-inequality-the-future-of-hiv-5/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinvancouver.com/wp-content/uploads/sites/1/2021/11/Zoom-banner_World-AIDS-Day_v1-980x306-1.png
ORGANIZER;CN="CIHR Canadian HIV Trials Network":MAILTO:ctninfo@hivnet.ubc.ca
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20211202T093000
DTEND;TZID=America/Vancouver:20211202T110000
DTSTAMP:20260405T050708
CREATED:20211115T010141Z
LAST-MODIFIED:20211115T010141Z
UID:19358-1638437400-1638442800@scienceinvancouver.com
SUMMARY:Blakes Breakfast Speaking Series: Neurological Diseases
DESCRIPTION:The Blakes Breakfast Speaking Series is our longest-standing event series and one of our most popular. These breakfasts include presentations by local\, national\, and multinational life science companies and typically attract a cross-section of our life sciences community members. The Breakfast Speaking Series is proudly presented by Blake\, Cassels & Graydon LLP. \nSpeakers:\n\nPaul Brennan\, President & CEO\, NervGen Pharma Corp.\nEric Roos\, Chief Business Development Officer\, Aspect Biosystems\nDr. Stephanie Willerth\, CEO\, Axolotl Biosciences\n\n\n\n\n\nEvent Details:\nDate: Thursday\, December 2\, 2021 \nTime: 9:30 AM to 11:00 AM PT \nPlatform: Zoom \nTickets: Free for Life Sciences BC members & $25 for non-members
URL:https://scienceinvancouver.com/event/blakes-breakfast-speaking-series-neurological-diseases/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20211202T093000
DTEND;TZID=America/Vancouver:20211202T110000
DTSTAMP:20260405T050708
CREATED:20211115T010141Z
LAST-MODIFIED:20211115T010141Z
UID:26469-1638437400-1638442800@scienceinvancouver.com
SUMMARY:Blakes Breakfast Speaking Series: Neurological Diseases
DESCRIPTION:The Blakes Breakfast Speaking Series is our longest-standing event series and one of our most popular. These breakfasts include presentations by local\, national\, and multinational life science companies and typically attract a cross-section of our life sciences community members. The Breakfast Speaking Series is proudly presented by Blake\, Cassels & Graydon LLP. \nSpeakers:\n\nPaul Brennan\, President & CEO\, NervGen Pharma Corp.\nEric Roos\, Chief Business Development Officer\, Aspect Biosystems\nDr. Stephanie Willerth\, CEO\, Axolotl Biosciences\n\n\n\n\n\nEvent Details:\nDate: Thursday\, December 2\, 2021 \nTime: 9:30 AM to 11:00 AM PT \nPlatform: Zoom \nTickets: Free for Life Sciences BC members & $25 for non-members
URL:https://scienceinvancouver.com/event/blakes-breakfast-speaking-series-neurological-diseases-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20211202T093000
DTEND;TZID=America/Vancouver:20211202T110000
DTSTAMP:20260405T050708
CREATED:20211115T010141Z
LAST-MODIFIED:20211115T010141Z
UID:28084-1638437400-1638442800@scienceinvancouver.com
SUMMARY:Blakes Breakfast Speaking Series: Neurological Diseases
DESCRIPTION:The Blakes Breakfast Speaking Series is our longest-standing event series and one of our most popular. These breakfasts include presentations by local\, national\, and multinational life science companies and typically attract a cross-section of our life sciences community members. The Breakfast Speaking Series is proudly presented by Blake\, Cassels & Graydon LLP. \nSpeakers:\n\nPaul Brennan\, President & CEO\, NervGen Pharma Corp.\nEric Roos\, Chief Business Development Officer\, Aspect Biosystems\nDr. Stephanie Willerth\, CEO\, Axolotl Biosciences\n\n\n\n\n\nEvent Details:\nDate: Thursday\, December 2\, 2021 \nTime: 9:30 AM to 11:00 AM PT \nPlatform: Zoom \nTickets: Free for Life Sciences BC members & $25 for non-members
URL:https://scienceinvancouver.com/event/blakes-breakfast-speaking-series-neurological-diseases-3/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20211202T093000
DTEND;TZID=America/Vancouver:20211202T110000
DTSTAMP:20260405T050708
CREATED:20211115T010141Z
LAST-MODIFIED:20211115T010141Z
UID:31167-1638437400-1638442800@scienceinvancouver.com
SUMMARY:Blakes Breakfast Speaking Series: Neurological Diseases
DESCRIPTION:The Blakes Breakfast Speaking Series is our longest-standing event series and one of our most popular. These breakfasts include presentations by local\, national\, and multinational life science companies and typically attract a cross-section of our life sciences community members. The Breakfast Speaking Series is proudly presented by Blake\, Cassels & Graydon LLP. \nSpeakers:\n\nPaul Brennan\, President & CEO\, NervGen Pharma Corp.\nEric Roos\, Chief Business Development Officer\, Aspect Biosystems\nDr. Stephanie Willerth\, CEO\, Axolotl Biosciences\n\n\n\n\n\nEvent Details:\nDate: Thursday\, December 2\, 2021 \nTime: 9:30 AM to 11:00 AM PT \nPlatform: Zoom \nTickets: Free for Life Sciences BC members & $25 for non-members
URL:https://scienceinvancouver.com/event/blakes-breakfast-speaking-series-neurological-diseases-4/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20211202T093000
DTEND;TZID=America/Vancouver:20211202T110000
DTSTAMP:20260405T050708
CREATED:20211115T010141Z
LAST-MODIFIED:20211115T010141Z
UID:32627-1638437400-1638442800@scienceinvancouver.com
SUMMARY:Blakes Breakfast Speaking Series: Neurological Diseases
DESCRIPTION:The Blakes Breakfast Speaking Series is our longest-standing event series and one of our most popular. These breakfasts include presentations by local\, national\, and multinational life science companies and typically attract a cross-section of our life sciences community members. The Breakfast Speaking Series is proudly presented by Blake\, Cassels & Graydon LLP. \nSpeakers:\n\nPaul Brennan\, President & CEO\, NervGen Pharma Corp.\nEric Roos\, Chief Business Development Officer\, Aspect Biosystems\nDr. Stephanie Willerth\, CEO\, Axolotl Biosciences\n\n\n\n\n\nEvent Details:\nDate: Thursday\, December 2\, 2021 \nTime: 9:30 AM to 11:00 AM PT \nPlatform: Zoom \nTickets: Free for Life Sciences BC members & $25 for non-members
URL:https://scienceinvancouver.com/event/blakes-breakfast-speaking-series-neurological-diseases-5/
LOCATION:Online
END:VEVENT
END:VCALENDAR